Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: A randomized pilot study

Journal of Clinical Psychiatry

Volumn 73, Issue 9, 2012, Pages 1179-1186

  Nave, Andrea M ^a   Tolin, David F ^a,b   Stevens, Michael C ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CYCLOSERINE; DESVENLAFAXINE; DULOXETINE; PAROXETINE; PLACEBO; SERTRALINE;

ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DSM-IV; EMOTION; EXPOSURE THERAPY; FEAR; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LEARNING; MALE; NERVE POTENTIAL; NERVE TRACT; ORBITAL CORTEX; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PERIGENUAL ANTERIOR CINGULATE; PHOBIA; PILOT STUDY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SNAKE; SNAKE PHOBIA; STIMULUS RESPONSE; SUBGENUAL ANTERIOR CINGULATE; THERAPY; TREATMENT RESPONSE; VENTROMEDIAL PREFRONTAL CORTEX;

EID: 84866499683     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07564     Document Type: Article

References (55)

1. Norberg MM, Krystal JH, Tolin DF. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry. 2008;63(12):1118-1126. doi:10.1016/j.biopsych.208.01.012 PubMed
2. Akirav I. NMDA Partial agonist reverses blocking of extinction of aversive memory by GABA(A) agonist in the amygdala. Neuropsychopharmacology. 2007;32(3):542-550. doi:10.1038/sj.np.1301050 PubMed
3. Davis M, Walker DL, Myers KM. Role of the amygdala in fear extinction measured with potentiated startle. Ann N Y Acad Sci. 2003;985(1): 218-232. doi:10.1/j.1749-632.203.tb07084.x PubMed
4. Larson CL, Schaefer HS, Siegle GJ, et al. Fear is fast in phobic individuals: amygdala activation in response to fear-relevant stimuli. Biol Psychiatry. 2006;60(4):410-417. doi:10.1016/j.biopsych.206.03.079 PubMed
5. Goossens L, Schruers K, Peeters R, et al. Visual presentation of phobic stimuli: amygdala activation via an extrageniculostriate pathway? Psychiatry Res. 2007;155(2):113-120. doi:10.1016/j.pscychresns.206.12.05 PubMed
6. Schienle A, Schäfer A, Walter B, et al. Brain activation of spider phobics towards disorder-relevant, generally disgust- and fear-inducing pictures. Neurosci Lett. 2005;388(1):1-6. doi:10.1016/j.neulet.205.06.025 PubMed
7. Lueken U, Kruschwitz JD, Muehlhan M, et al. How specific is specific phobia? different neural response patterns in two subtypes of specific phobia. Neuroimage. 2011;56(1):363-372. doi:10.1016/j.neuroimage.201.02.015 PubMed
8. Schienle A, Schäfer A, Hermann A, et al. Symptom provocation and reduction in patients suffering from spider phobia: an fMRI study on exposure therapy. Eur Arch Psychiatry Clin Neurosci. 2007;257(8): 486-493. doi:10.107/s0406-07-0754-y PubMed
9. Dilger S, Straube T, Mentzel HJ, et al. Brain activation to phobia-related pictures in spider phobic humans: an event-related functional magnetic resonance imaging study. Neurosci Lett. 2003;348(1):29-32. doi:10.1016/S0304-3940(03)0647-5 PubMed
10. Paquette V, Lévesque J, Mensour B, et al. "Change the mind and you change the brain": effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage. 2003;18(2):401-409. doi:10.1016/S1053-819(02)030-7 PubMed
11. Sehlmeyer C, Schöning S, Zwitserlood P, et al. Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS ONE. 2009;4(6):e5865. doi:10.1371/journal.pone.05865 PubMed
12. Sotres-Bayon F, Cain CK, LeDoux JE. Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry. 2006;60(4):329-336. doi:10.1016/j.biopsych.205.10.012 PubMed
13. Gottfried JA, Dolan RJ. Human orbitofrontal cortex mediates extinction learning while accessing conditioned representations of value. Nat Neurosci. 2004;7(10):1144-1152. doi:10.1038/n1314 PubMed
14. Knight DC, Smith CN, Cheng DT, et al. Amygdala and hippocampal activity during acquisition and extinction of human fear conditioning. Cogn Affect Behav Neurosci. 2004;4(3):317-325. doi:10.3758/CABN.4.3.317 PubMed
15. LaBar KS, Gatenby JC, Gore JC, et al. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron. 1998;20(5):937-945. doi:10.1016/S0896-6273(0)80475-4 PubMed
16. Phelps EA, Delgado MR, Nearing KI, et al. Extinction learning in humans: role of the amygdala and vmPFC. Neuron. 2004;43(6):897-905. doi:10.1016/j. neuron.204.08.042 PubMed
17. Molchan SE, Sunderland T, McIntosh AR, et al. A functional anatomical study of associative learning in humans. Proc Natl Acad Sci U S A. 1994;91(17):8122-8126. doi:10.1073/pnas.91.17.812 PubMed
18. Yágüez L, Coen S, Gregory LJ, et al. Brain response to visceral aversive conditioning: a functional magnetic resonance imaging study. Gastroenterology. 2005;128(7):1819-1829. doi:10.1053/j.gastro.205.02.068 PubMed
19. Hugdahl K, Berardi A, Thompson WL, et al. Brain mechanisms in human classical conditioning: a PET blood flow study. Neuroreport. 1995;6(13):1723-1728. doi:10.1097/01756-195090-05 PubMed
20. Finger EC, Mitchell DG, Jones M, et al. Dissociable roles of medial orbitofrontal cortex in human operant extinction learning. Neuroimage. 2008;43(4):748-755. doi:10.1016/j.neuroimage.208.08.021 PubMed
21. Delgado MR, Nearing KI, Ledoux JE, et al. Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron. 2008;59(5):829-838. doi:10.1016/j.neuron.208.06.029 PubMed
22. Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information. Psychol Bull. 1986;99(1):20-35. doi:10.1037/03-2909.9.1.20 PubMed
23. Straube T, Glauer M, Dilger S, et al. Effects of cognitive-behavioral therapy on brain activation in specific phobia. Neuroimage. 2006;29(1):125-135. doi:10.1016/j.neuroimage.205.07.07 PubMed
24. Goossens L, Sunaert S, Peeters R, et al. Amygdala hyperfunction in phobic fear normalizes after exposure. Biol Psychiatry. 2007;62(10):1119-1125. doi:10.1016/j.biopsych.207.04.024 PubMed
25. Britton JC, Gold AL, Feczko EJ, et al. D-Cycloserine inhibits amygdala responses during repeated presentations of faces. CNS Spectr. 2007;12(8):600-605. PubMed
26. Onur OA, Schlaepfer TE, Kukolja J, et al. The N-methyl-D-aspartate receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans. Biol Psychiatry. 2010;67(12):1205-1211. doi:10.1016/j.biopsych.2010.01.02 PubMed
27. Aupperle RL, Hale LR, Chambers RJ, et al. An fMRI study examining effects of acute D-cycloserine during symptom provocation in spider phobia. CNS Spectr. 2009;14(10):556-571. PubMed
28. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33. PubMed
29. Klorman R, Weerts TC, Hastings JE, et al. Psychometric description of some specific fear questionnaires. Behav Ther. 1974;5(3):401-409. doi:10.1016/S05-7894(74)808-0
30. Öst LG. Fading vs systematic desensitization in the treatment of snake and spider phobia. Behav Res Ther. 1978;16(6):379-389. doi:10.1016/05-7967(78)909-8 PubMed
31. Fredrikson M. Reliability and validity of some specific fear questionnaires. Scand J Psychol. 1983;24(4):331-334. doi:10.1/j.1467-9450.1983. tb0507.x PubMed
32. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976:218-222.
33. Öst LG. One-session treatment for specific phobias. Behav Res Ther. 1989;27(1):1-7. doi:10.1016/05-7967(89)9013-7 PubMed
34. Öst LG, Brandberg M, Alm T. One versus five sessions of exposure in the treatment of flying phobia. Behav Res Ther. 1997;35(11):987-996. doi:10.1016/S05-7967(97)07-6 PubMed
35. Friston KJ, Ashburner J, Frith CD, et al. Spatial registration and normalization of images. Hum Brain Mapp. 1995;3(3):165-189. doi:10.102/hbm. 46030303
36. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage. 2002;15(4):870-878. doi:10.106/nimg.201.1037 PubMed
37. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6(2):65-70.
38. Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry. 2008;13(9):829, 833-857. doi:10.1038/mp.208.82 PubMed
39. Morgan MA, LeDoux JE. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci. 1995;109(4):681-688. doi:10.1037/0735-704.109.4.681 PubMed
40. Morgan MA, Romanski LM, LeDoux JE. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett. 1993;163(1):109-113. doi:10.1016/0304-3940(93)90241-C PubMed
41. Nieuwenhuis IL, Takashima A. The role of the ventromedial prefrontal cortex in memory consolidation. Behav Brain Res. 2011;218(2):325-334. doi:10.1016/j.br.2010.12.09 PubMed
42. Lang PJ. Presidential address, 1978: a bio-informational theory of emotional imagery. Psychophysiology. 1979;16(6):495-512. doi:10.1/j.1469-8986. 1979.tb0151.x PubMed
43. Guastella AJ, Richardson R, Lovibond PF, et al. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry. 2008;63(6):544-549. doi:10.1016/j.biopsych.207.1.01 PubMed
44. Craig AD. Significance of the insula for the evolution of human awareness of feelings from the body. Ann N Y Acad Sci. 2011;1225(1):72-82. doi:10.1/j.1749-632.201.0590.x PubMed
45. Ibañez A, Gleichgerrcht E, Manes F. Clinical effects of insular damage in humans. Brain Struct Funct. 2010;214(5-6):397-410. doi:10.107/s0429-010-0256-y PubMed
46. Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct. 2010;214(5-6):655-667. doi:10.107/s0429-010-0262-0 PubMed
47. Nelson SM, Dosenbach NU, Cohen AL, et al. Role of the anterior insula in task-level control and focal attention. Brain Struct Funct. 2010;214(5-6):669- 680. doi:10.107/s0429-010-0260-2 PubMed
48. Ressler KJ, Rothbaum BO, Tannenbaum L, et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry. 2004;61(11):1136-1144. doi:10.101/archpsyc.61.1.136 PubMed
49. Hofmann SG, Meuret AE, Smits JA, et al. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006;63(3):298-304. doi:10.101/archpsyc.63.3.298 PubMed
50. Guastella AJ, Lovibond PF, Dadds MR, et al. A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans. Behav Res Ther. 2007;45(4):663-672. doi:10.1016/j.brat.206.07.05 PubMed
51. Guastella AJ, Dadds MR, Lovibond PF, et al. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. J Psychiatr Res. 2007;41(6):466-471. doi:10.1016/j.jpsychires.206.05.06 PubMed
52. Chasson GS, Buhlmann U, Tolin DF, et al. Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with D-cycloserine. Behav Res Ther. 2010;48(7):675-679. doi:10.1016/j.brat.2010.03.07 PubMed
53. Walker DL, Ressler KJ, Lu KT, et al. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci. 2002;22(6):2343-2351. PubMed
54. Siegmund A, Golfels F, Finck C, et al. D-Cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial. J Psychiatr Res. 2011;45(8):1042-1047. doi:10.1016/j.jpsychires.201.01. 020 PubMed
55. Chasson GS, Buhlmann U, Tolin DF, et al. The need for speed: enhancing behavior therapy for OCD by utilizing D-cycloserine. Paper presented at the 43rd Annual Meeting of the Association of Behavioral and Cognitive Therapies; November 19-22, 2009; New York, NY.